These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2505294)

  • 1. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal.
    Koob GF; Wall TL; Bloom FE
    Psychopharmacology (Berl); 1989; 98(4):530-4. PubMed ID: 2505294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal.
    Stinus L; Le Moal M; Koob GF
    Neuroscience; 1990; 37(3):767-73. PubMed ID: 2247222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats.
    Walker JR; Ahmed SH; Gracy KN; Koob GF
    Brain Res; 2000 Jan; 854(1-2):85-92. PubMed ID: 10784110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence.
    Criner SH; Liu J; Schulteis G
    Neuroscience; 2007 Feb; 144(4):1436-46. PubMed ID: 17161915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat.
    Amalric M; Koob GF
    Pharmacol Biochem Behav; 1985 Sep; 23(3):411-5. PubMed ID: 4048236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex.
    Rada PV; Mark GP; Taylor KM; Hoebel BG
    Pharmacol Biochem Behav; 1996 Apr; 53(4):809-16. PubMed ID: 8801582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinforcing effects of morphine in the nucleus accumbens.
    Olds ME
    Brain Res; 1982 Apr; 237(2):429-40. PubMed ID: 7083004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic opiate administration has heterogeneous effects on activity recorded from nucleus accumbens neurons in vivo.
    Hakan RL; Henriksen SJ
    Neurosci Lett; 1987 Dec; 83(3):307-12. PubMed ID: 3441313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-administration of methionine enkephalin into the nucleus accumbens.
    Goeders NE; Lane JD; Smith JE
    Pharmacol Biochem Behav; 1984 Mar; 20(3):451-5. PubMed ID: 6324244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine.
    Rada P; Pothos E; Mark GP; Hoebel BG
    Brain Res; 1991 Oct; 561(2):354-6. PubMed ID: 1802350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.
    Valverde O; Tzavara E; Hanoune J; Roques BP; Maldonado R
    Eur J Neurosci; 1996 Dec; 8(12):2671-8. PubMed ID: 8996817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
    Maldonado R; Stinus L; Gold LH; Koob GF
    J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes.
    Laviolette SR; Nader K; van der Kooy D
    Behav Brain Res; 2002 Feb; 129(1-2):17-29. PubMed ID: 11809491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aversive properties of opiate withdrawal studied in rats.
    Mucha RF; Gritti MD; Kim C
    NIDA Res Monogr; 1986; 75():567-70. PubMed ID: 3123976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
    Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
    Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.
    Russell SE; Puttick DJ; Sawyer AM; Potter DN; Mague S; Carlezon WA; Chartoff EH
    J Neurosci; 2016 May; 36(21):5748-62. PubMed ID: 27225765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats.
    Dwoskin LP; Neal BS; Sparber SB
    Eur J Pharmacol; 1983 Jun; 90(2-3):269-73. PubMed ID: 6683657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A thalamic input to the nucleus accumbens mediates opiate dependence.
    Zhu Y; Wienecke CF; Nachtrab G; Chen X
    Nature; 2016 Feb; 530(7589):219-22. PubMed ID: 26840481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesions of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats.
    Kelsey JE; Arnold SR
    Behav Neurosci; 1994 Dec; 108(6):1119-27. PubMed ID: 7893404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.